Longitudinal follow-up of vision in a neuromyelitis optica cohort

Abstract

Background:

Neuromyelitis optica (NMO) is an inflammatory disease associated with optic neuritis and myelitis. Recently, several studies showed that optical coherence tomography (OCT) could be an interesting method for the evaluation of disease severity; however, to date there are no studies with a longitudinal follow-up of visual function in NMO. The aim of this study was to assess the ability of OCT to evaluate the progression of visual dysfunction in NMO.

Patients and methods:

A group of 30 NMO patients (thus, 60 eyes), comprised of 20 women and 10 men with a mean age of 43.7 +/− 12.3 years, were prospectively evaluated clinically and by a whole neuro-ophthalmological work-up, including: visual acuity (VA), fundoscopy, visual evoked potential (VEP), visual field (VF) and optical coherence tomography (OCT). All patients were tested at baseline (after a mean disease duration of 6.1 years) and after a mean time of follow-up of 18 months (range: 12–36 months).

Results:

Mean VA was similar at the two evaluation times (0.77 +/− 0.36 versus 0.77 +/− 0.35). The mean VF defect decreased slightly, but the difference was not significant (−5.9 +/− 1.3 dB versus −5.3 +/− 1.3 dB). In contrast, the mean retinal thickness seen on OCT decreased from 87.4 +/− 23.3 µm to 79.7 +/- 22.4 µm (p = 0.006). These modifications were only observed in eyes with a past or a recent history of optic neuritis (−15.1 µm; p < 0.001) and not in eyes without any history of optic neuritis (−2.4 µm; not significant). Also, they occurred independently of the occurrence of relapses (n = 13) and especially optic neuritis episodes; however, the number of optic neuritis episodes was low (n = 5).

Conclusion:

OCT seems to be a more sensitive test than VA or VF for monitoring ophthalmological function in NMO and it seems to be helpful for the detection of infra-clinical episodes in patients with a past history of optic neuritis. Our results suggest that this easily performed technique should be used in the follow-up of NMO, but complementary studies are warranted to confirm its interest at an individual level.

Keywords

Neuromyelitis optica optic neuritis optical coherence tomography retinal thickness longitudinal study visual dysfunction visual tests

Get full access to this article

View all access options for this article.

References

De Seze

Blanc

Jeanjean

. Optical coherence tomography in neuromyelitis optica. Arch Neurol. 2008; 65: 920–923.

Merle

Olindo

Donnio

. Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica. Invest Ophthalmol Vis Sci. 2008; 49: 4412–4417.

Rachford

Quigg

Conger

. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 2009; 73: 302–308.

Sepulcre

Fernandez

Salinas-Alaman

. Diagnosis accuracy of retinal abnormalities in predicting disease activity in MS. Neurology 2007; 68: 1488–1494.

Garcia-Martin

Pueyo

Ara

. Effect of optic neuritis on progressive axonal damage in multiple sclerosis patients. Mult Scler 2011; 17: 830–837.

Henderson

Trip

Schlottmann

. A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis. J Neurol 2010; 257: 1083–1091.

Talman

Bisker

Sackel

. Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 2010; 67: 749–760.

Garcia-Martin

Pueyo

Martin

. Progressive changes in the retinal nerve fiber layer in patients with multiple sclerosis. Eur J Ophthalmol 2010; 20: 167–173.

Galetta

Graves

Talman

. Visual pathway axonal loss in benign multiple sclerosis: A longitudinal study. J Neuro-Ophthalmology 2012; 32: 116–123.

10.

Wingerchuk

Lennon

Pittock

. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485–1489.

11.

Wingerchuk

Pittock

Lucchinetti

. A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology 2007; 68: 603–605.

12.

Garcia-Martin

Pueyo

Pinilla

. Fourier-domain OCT in multiple sclerosis patients: eproducibility and ability to detect retinal nerve fiber layer atrophy. Invest Ophthalmol Vis Sci. 2011; 52: 4124–4131.

13.

Timmers

Hunter

. Non-invasive imaging by optical coherence tomography to monitor retinal degeneration in the mouse. Invest Ophthalmol Vis Sci 2001; 42: 2981–2989.

14.

Horio

Kachi

Hori

. Progressive change of optical coherence tomography scans in retinal degeneration slow mice. Arch Ophthalmol 2001; 119: 1329–1332.

15.

Grieve

Paques

Dubois

. Ocular tissue imaging using ultrahigh-resolution, full-field optical coherence tomography. Invest Ophthalmol Vis Sci 2004; 45: 4126–4131.